Phobias

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

2. Freeman D, Lambe S, Yu LM, et al. Injection fears and COVID-19 vaccine hesitancy. Psychol Med. 2021 Jun 11;:1-11.[Abstract][Full Text]

3. Stinson FS, Dawson DA, Chou SP, et al. The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2007 Jul;37(7):1047-59.[Abstract]

4. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593-602.[Abstract][Full Text]

5. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):617-27.[Abstract][Full Text]

6. Kim SJ, Kim BN, Cho SC, et al. The prevalence of specific phobia and associated co-morbid features in children and adolescents. J Anxiety Disord. 2010 Aug;24(6):629-34.[Abstract]

7. Ollendick TH, King NJ, Muris P. Fears and phobias in children: phenomenology, epidemiology and aetiology. Child Adolesc Ment Health. 2002;7(3):98-106.

8. Kessler RC, Petukhova M, Sampson NA, et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012 Sep;21(3):169-84.[Abstract][Full Text]

9. Greiner S, Schuurmans J, Goldfarb M, et al. The epidemiology of specific phobia and subthreshold fear subtypes in a community-based sample of older adults. Depress Anxiety. 2011 Jun;28(6):456-63.[Abstract]

10. Wardenaar KJ, Lim CCW, Al-Hamzawi AO, et al. The cross-national epidemiology of specific phobia in the World Mental Health Surveys. Psychol Med. 2017 Jul;47(10):1744-60.[Abstract][Full Text]

11. Arrindell WA, Eisemann M, Richter J, et al. Phobic anxiety in 11 nations. Part 1: dimensional constancy of the five-factor model. Behav Res Ther. 2003 Apr;41(4):461-79.[Abstract]

12. Pull CB. Recent trends in the study of specific phobias. Curr Opin Psychiatry. 2008 Jan;21(1):43-50.[Abstract]

13. Davey GC, McDonald AS, Hirisave U, et al. A cross-cultural study of animal fears. Behav Res Ther. 1998 Jul-Aug;36(7-8):735-50.[Abstract]

14. Rachman S. The conditioning theory of fear-acquisition: a critical examination. Behav Res Ther. 1977;15(5):375-87.[Abstract]

15. Olatunji BO, Sawchuk CN. Disgust: characteristic features, social manifestations, and clinical implications. J Soc Clin Psychol. 2005;24(7):932-62.

16. Poulton R, Menzies RG. Non-associative fear acquisition: a review of the evidence from retrospective and longitudinal research. Behav Res Ther. 2002 Feb;40(2):127-49.[Abstract]

17. Van Houtem CM, Laine ML, Boomsma DI, et al. A review and meta-analysis of the heritability of specific phobia subtypes and corresponding fears. J Anxiety Disord. 2013 May;27(4):379-88.[Abstract]

18. Goossens L, Sunaert S, Peeters R, et al. Amygdala hyperfunction in phobic fear normalizes after exposure. Biol Psychiatry. 2007 Nov 15;62(10):1119-25.[Abstract]

19. Straube T, Mentzel HJ, Miltner WH. Neural mechanisms of automatic and direct processing of phobogenic stimuli in specific phobia. Biol Psychiatry. 2006 Jan 15;59(2):162-70.[Abstract]

20. Schienle A, Schafer A, Walter B, et al. Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing pictures. Neurosci Lett. 2005 Nov 4;388(1):1-6.[Abstract]

21. Straube T, Mentzel HJ, Miltner WH. Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. Neuroimage. 2007 Oct 1;37(4):1427-36.[Abstract]

22. Damsa C, Kosel M, Moussally J, et al. Current status of brain imaging in anxiety disorders. Curr Opin Psychiatry. 2009 Jan;22(1):96-110.[Abstract]

23. Ipser JC, Singh L, Stein DJ. Meta-analysis of functional brain imaging in specific phobia. Psychiatry Clin Neurosci. 2013 Jul;67(5):311-22.[Abstract][Full Text]

24. Michelgard A, Appel L, Pissiota A, et al. Symptom provocation in specific phobia affects substance P neurokinin-1 receptor system. Biol Psychiatry. 2007 Apr 15;61(8):1002-6.[Abstract]

25. Del Casale A, Ferracuti S, Rapinesi C, et al. Functional neuroimaging in specific phobia. Psychiatry Res. 2012 Jun 30;202(3):181-97.[Abstract]

26. Ost LG. Blood and injection phobia: background and cognitive, physiological, and behavioral variables. J Abnorm Psychol. 1992 Feb;101(1):68-74.[Abstract]

27. Page AC. The role of disgust in faintness elicited by blood and injection stimuli. J Anxiety Disord. 2003;17(1):45-58.[Abstract]

28. Boyd JH, Rae DS, Thompson JW, et al. Phobia: prevalence and risk factors. Soc Psychiatry Psychiatr Epidemiol. 1990 Nov;25(6):314-23.[Abstract]

29. Jacobson NC, Newman MG. Anxiety and depression as bidirectional risk factors for one another: a meta-analysis of longitudinal studies. Psychol Bull. 2017 Nov;143(11):1155-200.[Abstract]

30. Fyer AJ, Mannuzza S, Chapman TF, et al. Specificity in familial aggregation of phobic disorders. Arch Gen Psychiatry. 1995 Jul;52(7):564-73.[Abstract]

31. Czajkowski N, Kendler KS, Tambs K, et al. The structure of genetic and environmental risk factors for phobias in women. Psychol Med. 2011 Sep;41(9):1987-95.[Abstract][Full Text]

32. Poulton R, Waldie KE, Craske MG, et al. Dishabituation processes in height fear and dental fear: an indirect test of the non-associative model of fear acquisition. Behav Res Ther. 2000 Sep;38(9):909-19.[Abstract]

33. Breinholst S, Esbjorn BH, Reinholdt-Dunne ML, et al. CBT for the treatment of child anxiety disorders: a review of why parental involvement has not enhanced outcomes. J Anxiety Disord. 2012 Apr;26(3):416-24.[Abstract]

34. Ollendick TH, Muris P. The scientific legacy of Little Hans and Little Albert: future directions for research on specific phobias in youth. J Clin Child Adolesc Psychol. 2015;44(4):689-706.[Abstract]

35. Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am. 2009 Sep;32(3):483-524.[Abstract][Full Text]

36. Cisler JM, Koster EH. Mechanisms of attentional biases towards threat in anxiety disorders: an integrative review. Clin Psychol Rev. 2010 Mar;30(2):203-16.[Abstract][Full Text]

37. Antony MM, Orsillo SM, Roemer L. Practitioner's guide to empirically based measures of anxiety. New York, Springer Publishing; 2001.

38. Becker ES, Rinck M, Türke V, et al. Epidemiology of specific phobia subtypes: findings from the Dresden Mental Health Study. Eur Psychiatry. 2006 Mar;22(2):69-74.[Abstract]

39. ​US Preventive Services Task Force. Screening for anxiety disorders in adults: US Preventive Services Task Force recommendation statement. JAMA. 2023 Jun 27;329(24):2163-70.[Abstract][Full Text]

40. US Preventive Services Task Force. Anxiety in children and adolescents: screening. Oct 2022 [internet publication].[Full Text]

41. Gregory KD, Chelmow D, Nelson HD, et al. Screening for anxiety in adolescent and adult women: a recommendation from the Women's Preventive Services Initiative. Ann Intern Med. 2020 Jul 7;173(1):48-56.[Abstract][Full Text]

42. First MB, Williams JBW, Karg RS, Spitzer RL. Structured clinical interview for DSM-5 disorders, clinician version (SCID-5-CV). Arlington, VA: American Psychiatric Association; 2015.

43. Brown TA, Barlow DH. Anxiety disorders interview schedule for DSM-5 (ADIS-5) - adult version. Oxford: Oxford University Press; 2014.

44. Albano AM, Silverman WK. Anxiety disorders interview schedule for DSM-IV, child/parent version. Albany, NY: Graywind Publications; 1996.

45. LeBeau RT, Glenn D, Liao B, et al. Specific phobia: a review of DSM-IV specific phobia and proposals for DSM-V. Depress Anxiety. 2010 Feb;27(2):148-67.[Abstract]

46. World Health Organization. ICD-11 International statistical classification of diseases and related health problems, 11th revision. Geneva: WHO; 2022.[Full Text]

47. Walter HJ, Bukstein OG, Abright AR, et al. Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2020 Oct;59(10):1107-24.[Abstract][Full Text]

48. Grös DF, Antony MM. The assessment and treatment of specific phobias: a review. Curr Psychiatry Rep. 2006 Aug;8(4):298-303.[Abstract]

49. Antony MM, Barlow DH. Specific phobias. In: Barlow DH, ed. Anxiety and its disorders: the nature and treatment of anxiety and panic. 2nd ed. New York, NY: Guilford Press; 2002:380-417.

50. Wolitzky-Taylor KB, Horowitz JD, Powers MB, et al. Psychological approaches in the treatment of specific phobias: a meta-analysis. Clin Psychol Rev. 2008 Jul;28(6):1021-37.[Abstract]

51. Katzman MA, Bleau P, Blier P, et al; Anxiety Disorders Association of Canada; McGill University. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14 Suppl 1:S1.[Abstract][Full Text]

52. Zlomke K, Davis TE. One-session treatment of specific phobias: a detailed description and review of treatment efficacy. Behav Ther. 2008 Sep;39(3):207-23.[Abstract]

53. Davis TE 3rd, Ollendick TH. Intensive treatment of specific phobias in children and adolescents. Cogn Behav Pract. 2009 Aug 1;16(3):294-303.[Abstract]

54. Pompoli A, Furukawa TA, Imai H, et al. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. Cochrane Database Syst Rev. 2016 Apr 13;(4):CD011004.[Abstract][Full Text]

55. Choy Y, Fyer AJ, Lipsitz JD. Treatment of specific phobia in adults. Clin Psychol Rev. 2007 Apr;27(3):266-86.[Abstract]

56. Eaton WW, Bienvenu OJ, Miloyan B. Specific phobias. Lancet Psychiatry. 2018 Aug;5(8):678-86.[Abstract]

57. Gilroy L, Kirkby KC, Daniels BA, et al. Controlled comparison of computer-aided vicarious exposure versus live exposure in the treatment of spider phobia. Behav Ther. 2000;31:733-44. 

58. Menzies RG, Clarke JC. A comparison of in vivo and vicarious exposure in the treatment of childhood water phobia. Behav Res Ther. 1993 Jan;31(1):9-15.[Abstract]

59. Oar EL, Farrell LJ, Ollendick TH. One session treatment for specific phobias: an adaptation for paediatric blood-injection-injury phobia in youth. Clin Child Fam Psychol Rev. 2015 Dec;18(4):370-94.[Abstract]

60. Riddle-Walker L, Veale D, Chapman C, et al. Cognitive behaviour therapy for specific phobia of vomiting (Emetophobia): A pilot randomized controlled trial. J Anxiety Disord. 2016 Oct;43:14-22.[Abstract]

61. Böhnlein J, Altegoer L, Muck NK, et al. Factors influencing the success of exposure therapy for specific phobia: A systematic review. Neurosci Biobehav Rev. 2020 Jan;108:796-820.[Abstract]

62. Carl E, Stein AT, Levihn-Coon A, et al. Virtual reality exposure therapy for anxiety and related disorders: A meta-analysis of randomized controlled trials. J Anxiety Disord. 2018 Aug 10;61:27-36.[Abstract]

63. Boettcher H, Barlow DH. The unique and conditional effects of interoceptive exposure in the treatment of anxiety: a functional analysis. Behav Res Ther. 2018 Dec 6 [Epub ahead of print].[Abstract]

64. Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull. 1986 Jan;99(1):20-35.[Abstract]

65. Craske MG, Treanor M, Conway CC, et al. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014 Jul;58:10-23.[Abstract][Full Text]

66. Kircanski K, Mortazavi A, Castriotta N, et al. Challenges to the traditional exposure paradigm: variability in exposure therapy for contamination fears. J Behav Ther Exp Psychiatry. 2012 Jun;43(2):745-51.[Abstract]

67. Baker A, Mystkowski J, Culver N, et al. Does habituation matter? Emotional processing theory and exposure therapy for acrophobia. Behav Res Ther. 2010 Nov;48(11):1139-43.[Abstract][Full Text]

68. Davis TE, Ollendick TH, Öst LG. One-session treatment of phobias in children: recent developments and a systematic review. Annu Rev Clin Psychol. 2018 Dec 14 [Epub ahead of print].[Abstract]

69. Kothgassner OD, Felnhofer A. Lack of research on efficacy of virtual reality exposure therapy (VRET) for anxiety disorders in children and adolescents: a systematic review. Neuropsychiatr. 2021 Jun;35(2):68-75.[Abstract][Full Text]

70. Freitas JRS, Velosa VHS, Abreu LTN, et al. Virtual reality exposure treatment in phobias: a systematic review. Psychiatr Q. 2021 Dec;92(4):1685-1710.[Abstract]

71. Krijn M, Emmelkamp PM, Olafsson RP, et al. Virtual reality exposure therapy of anxiety disorders: a review. Clin Psychol Rev. 2004 Jul;24(3):259-81.[Abstract]

72. da Costa RT, Sardinha A, Nardi AE. Virtual reality exposure in the treatment of fear of flying. Aviat Space Environ Med. 2008 Sep;79(9):899-903.[Abstract]

73. Gujjar KR, van Wijk A, Kumar R, et al. Efficacy of virtual reality exposure therapy for the treatment of dental phobia in adults: a randomized controlled trial. J Anxiety Disord. 2019 Mar;62:100-8.[Abstract]

74. Freeman D, Haselton P, Freeman J, et al. Automated psychological therapy using immersive virtual reality for treatment of fear of heights: a single-blind, parallel-group, randomised controlled trial. Lancet Psychiatry. 2018 Aug;5(8):625-32.[Abstract][Full Text]

75. Coelho CM, Waters AM, Hine TJ, et al. The use of virtual reality in acrophobia research and treatment. J Anxiety Disord. 2009 Jun;23(5):563-74.[Abstract]

76. Wechsler TF, Kümpers F, Mühlberger A. Inferiority or even superiority of virtual reality exposure therapy in phobias? - A systematic review and quantitative meta-analysis on randomized controlled trials specifically comparing the efficacy of virtual reality exposure to gold standard in vivo exposure in agoraphobia, specific phobia, and social phobia. Front Psychol. 2019 Sep 10;10:1758.[Abstract][Full Text]

77. Parsons TD, Rizzo AA. Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis. J Behav Ther Exp Psychiatry. 2008 Sep;39(3):250-61.[Abstract]

78. Meyerbroker K, Emmelkamp PM. Virtual reality exposure therapy in anxiety disorders: a systematic review of process-and-outcome studies. Depress Anxiety. 2010 Oct;27(10):933-44.[Abstract]

79. Morina N, Ijntema H, Meyerbröker K, et al. Can virtual reality exposure therapy gains be generalized to real-life? A meta-analysis of studies applying behavioral assessments. Behav Res Ther. 2015 Nov;74:18-24.[Abstract]

80. Jiang MYW, Upton E, Newby JM. A randomised wait-list controlled pilot trial of one-session virtual reality exposure therapy for blood-injection-injury phobias. J Affect Disord. 2020 Nov 1;276:636-45.[Abstract]

81. Ost LG, Sterner U. Applied tension: a specific behavioral method for treatment of blood phobia. Behav Res Ther. 1987;25(1):25-9.[Abstract]

82. Ayala ES, Meuret AE, Ritz T. Treatments for blood-injury-injection phobia: a critical review of current evidence. J Psychiatr Res. 2009 Oct;43(15):1235-42.[Abstract]

83. McMurtry CM, Taddio A, Noel M, et al. Exposure-based interventions for the management of individuals with high levels of needle fear across the lifespan: a clinical practice guideline and call for further research. Cogn Behav Ther. 2016 Apr;45(3):217-35.[Abstract][Full Text]

84. Ayala ES, Meuret AE, Ritz T. Confrontation with blood and disgust stimuli precipitates respiratory dysregulation in blood-injection-injury phobia. Biol Psychol. 2010 Apr;84(1):88-97.[Abstract]

85. Meuret AE, Simon E, Bhaskara L, et al. Ultra-brief behavioral skills trainings for blood injection injury phobia. Depress Anxiety. 2017 Dec;34(12):1096-105.[Abstract]

86. Otto MW, McHugh RK, Kantak KM. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders: medication effects, glucocorticoids, and attenuated treatment outcomes. Clin Psychol (New York). 2010 Jun 1;17(2):91-103.[Abstract][Full Text]

87. Haug T, Nordgreen T, Öst LG, et al. Self-help treatment of anxiety disorders: a meta-analysis and meta-regression of effects and potential moderators. Clin Psychol Rev. 2012 Jul;32(5):425-45.[Abstract]

88. Marks IM. Living with fear. 2nd ed. New York, NY: McGraw-Hill; 2001.

89. Schneider AJ, Mataix-Cols D, Marks IM, et al. Internet-guided self-help with or without exposure therapy for phobic and panic disorders. Psychother Psychosom. 2005;74(3):154-64.[Abstract]

90. Reger MA, Gahm GA. A meta-analysis of the effects of internet- and computer-based cognitive-behavioral treatments for anxiety. J Clin Psychol. 2009 Jan;65(1):53-75.[Abstract]

91. Ferriter M, Kaltenthaler E, Parry G, et al. Computerised cognitive behaviour therapy for phobias and panic disorder: a systematic review (Provisional abstract). J Pub Ment Health. 2008;7:15-22.

92. Olthuis JV, Watt MC, Bailey K, et al. Therapist-supported internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2016 Mar 12;(3):CD011565.[Abstract][Full Text]

93. Mor S, Grimaldos J, Tur C, et al. Internet- and mobile-based interventions for the treatment of specific phobia: A systematic review and preliminary meta-analysis. Internet Interv. 2021 Dec;26:100462.[Abstract][Full Text]

94. Manassis K, Lee TC, Bennett K, et al. Types of parental involvement in CBT with anxious youth: a preliminary meta-analysis. J Consult Clin Psychol. 2014 Dec;82(6):1163-72.[Abstract]

95. Walczak M, Esbjørn BH, Breinholst S, et al. Parental involvement in cognitive behavior therapy for children with anxiety disorders: 3-year follow-up. Child Psychiatry Hum Dev. 2017 Jun;48(3):444-54.[Abstract]

96. Ost LG. One-session group treatment of spider phobia. Behav Res Ther. 1996 Sep;34(9):707-15.[Abstract]

97. Van Gerwen LJ, Spinhoven P, Van Dyck R. Behavioral and cognitive group treatment for fear of flying: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2006 Dec;37(4):358-71.[Abstract]

98. Wannemueller A, Gruszka P, Chwalek S, et al. Large-group one-session treatment: feasibility in highly height fearful individuals and predictors of outcome. Front Psychol. 2019 Oct 24;10:2411.[Abstract][Full Text]

99. Lilliecreutz C, Josefsson A, Sydsjö G. An open trial with cognitive behavioral therapy for blood- and injection phobia in pregnant women-a group intervention program. Arch Womens Ment Health. 2010 Jun;13(3):259-65.[Abstract]

100. Ollendick TH, Davis TE 3rd. One-session treatment for specific phobias: a review of Öst's single-session exposure with children and adolescents. Cogn Behav Ther. 2013;42(4):275-83.[Abstract]

101. Lebowitz ER, Panza KE, Bloch MH. Family accommodation in obsessive-compulsive and anxiety disorders: a five-year update. Expert Rev Neurother. 2016;16(1):45-53.[Abstract][Full Text]

102. Lewis KM, Amatya K, Coffman MF, et al. Treating nighttime fears in young children with bibliotherapy: evaluating anxiety symptoms and monitoring behavior change. J Anxiety Disord. 2015 Mar;30:103-12.[Abstract]

103. Vigerland S, Ljótsson B, Thulin U, et al. Internet-delivered cognitive behavioural therapy for children with anxiety disorders: a randomised controlled trial. Behav Res Ther. 2016 Jan;76:47-56.[Abstract][Full Text]

104. Manassis K, Mendlowitz SL, Scapillato D, et al. Group and individual cognitive-behavioral therapy for childhood anxiety disorders: a randomized trial. J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1423-30.[Abstract]

105. Liber JM, Van Widenfelt BM, Utens EM, et al. No differences between group versus individual treatment of childhood anxiety disorders in a randomised clinical trial. J Child Psychol Psychiatry. 2008 Aug;49(8):886-93.[Abstract]

106. Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry. 2004 Nov;61(11):1136-44.[Abstract][Full Text]

107. Byrne SP, Rapee RM, Richardson R, et al. D-cycloserine enhances generalization of fear extinction in children. Depress Anxiety. 2015 Jun;32(6):408-14.[Abstract]

108. Smits JA, Rosenfield D, Otto MW, et al. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol Psychiatry. 2013 Jun 1;73(11):1054-8.[Abstract][Full Text]

109. Ori R, Amos T, Bergman H, et al. Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. Cochrane Database Syst Rev. 2015 May 10;(5):CD007803.[Abstract][Full Text]

110. Mataix-Cols D, Fernández de la Cruz L, Monzani B, et al. D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: a systematic review and meta-analysis of individual participant data. JAMA Psychiatry. 2017 May 1;74(5):501-10.[Abstract]

111. de Quervain D, Wolf OT, Roozendaal B. Glucocorticoid-induced enhancement of extinction-from animal models to clinical trials. Psychopharmacology (Berl). 2019 Jan;236(1):183-99.[Abstract]

112. de Quervain DJ, Bentz D, Michael T, et al. Glucocorticoids enhance extinction-based psychotherapy. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6621-5.[Abstract][Full Text]

113. Soravia LM, Heinrichs M, Winzeler L, et al. Glucocorticoids enhance in vivo exposure-based therapy of spider phobia. Depress Anxiety. 2014 May;31(5):429-35.[Abstract]

114. Eaton WW, Anthony JC, Gallo J, et al. Natural history of diagnostic interview schedule/DSM-IV major depression: the Baltimore epidemiologic catchment area follow-up. Arch Gen Psychiatry. 1997 Nov;54(11):993-9.[Abstract]

115. Magee WJ, Eaton WW, Wittchen HU, et al. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry. 1996 Feb;53(2):159-68.[Abstract]

116. Trumpf J, Becker ES, Vriends N, et al. Rates and predictors of remission in young women with specific phobia: a prospective community study. J Anxiety Disord. 2009 Oct;23(7):958-64.[Abstract]

117. Grös DF, Antony MM. The assessment and treatment of specific phobias: a review. Curr Psychiatry Rep. 2006 Aug;8(4):298-303.[Abstract]

118. Antony MM, Barlow DH. Specific phobias. In: Barlow DH, ed. Anxiety and its disorders: the nature and treatment of anxiety and panic. 2nd ed. New York, NY: Guilford Press; 2002:380-417.

119. Cemeroglu AP, Can A, Davis AT, et al. Fear of needles in children with type 1 diabetes mellitus on multiple daily injections and continuous subcutaneous insulin infusion. Endocr Pract. 2015 Jan;21(1):46-53.[Abstract]